-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Anebulo Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2020 to Q3 2022.
- Anebulo Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2022 was $6.7M.
- Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$62.4K, a 101% decline from 2023.
- Anebulo Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.38M.